ESTUDIO DE LAS ENFERMEDADES NEURODEGENERATIVAS EN ANDALUCIA
NEURODEGENERACION
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (4)
2021
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
2019
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
2014
-
Long-term effectiveness of glatiramer acetate in clinical practice conditions
Journal of Clinical Neuroscience, Vol. 21, Núm. 12, pp. 2212-2218
2005
-
Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)
Pharmacogenomics Journal, Vol. 5, Núm. 2, pp. 135-141